z-logo
open-access-imgOpen Access
CDK inhibitors and PARP inhibitors in current clinical practice
Author(s) -
Alexandru Grigorescu
Publication year - 2018
Publication title -
oncolog-hematolog ro
Language(s) - English
Resource type - Journals
eISSN - 2066-8716
pISSN - 2066-8260
DOI - 10.26416/onhe.42.1.2018.1552
Subject(s) - clinical trial , breast cancer , context (archaeology) , medicine , metastatic breast cancer , clinical practice , intensive care medicine , cyclin dependent kinase , cancer , oncology , biology , family medicine , cell cycle , paleontology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom